+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Preimplantation Genetic Testing Market by Testing Type, Test Type, Technology Type, Offering, End User - Global Forecast to 2030- Product Image
Preimplantation Genetic Testing Market by Testing Type, Test Type, Technology Type, Offering, End User - Global Forecast to 2030- Product Image
Sale

Preimplantation Genetic Testing Market by Testing Type, Test Type, Technology Type, Offering, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 189 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4968718
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The preimplantation genetic testing market is evolving rapidly as clinics and laboratories embrace advanced diagnostics to improve fertility outcomes. Senior decision-makers are navigating a complex environment of technological innovation, regulatory shifts, and increasing expectations for precise, patient-centric reproductive care.

Market Snapshot: Preimplantation Genetic Testing

The Preimplantation Genetic Testing Market grew from USD 780.19 million in 2024 to USD 873.74 million in 2025. It is expected to continue growing at a CAGR of 12.23%, reaching USD 1.55 billion by 2030. This robust expansion signals ongoing adoption of genetic screening across in vitro fertilization programs worldwide, driven by demand for routine, high-accuracy diagnostics in reproductive medicine. Rising patient awareness, expanding insurance coverage in selected regions, and ongoing investments by technology leaders contribute to this positive outlook.

Scope & Segmentation

This market analysis delivers actionable segmentation and comprehensive geographic coverage, enhancing strategic clarity for decision-making:

  • Testing Types:
    • PGT-A for aneuploidy detection
    • PGT-M for identification of monogenic disorders
    • PGT-SR addressing structural chromosomal rearrangements
  • Test Approaches:
    • Preimplantation genetic diagnosis targeting inherited mutations
    • Preimplantation genetic screening for overall embryo viability
  • Technology Platforms:
    • Comparative genomic hybridization
    • Fluorescent in-situ hybridization (FISH)
    • Next-generation sequencing (NGS) for high-throughput analysis
    • PCR-based testing for rapid results
    • Single-nucleotide polymorphism arrays
  • Offerings:
    • Instruments and capital equipment
    • Reagents and consumables
    • Analytical and visualization software
  • End Users:
    • Diagnostic laboratories
    • Fertility clinics integrating genetics
    • Hospital-based reproductive centers
    • Academic and private research institutes
  • Regions Covered:
    • Americas (notably United States, Canada, Brazil, Argentina, Mexico)
    • Europe, Middle East & Africa (including United Kingdom, France, Germany, UAE, South Africa, and others)
    • Asia-Pacific (with key markets such as China, India, Japan, Australia, Korea, Southeast Asia)
  • Key Companies Analyzed:
    • Abbott Laboratories, Agilent Technologies, Bioarray S.L., EUROPE IVF International, F. Hoffmann-La Roche AG, Illumina, Inc., Natera, NextGen Genetics, Ovation Fertility, Thermo Fisher Scientific Inc., among others

Key Takeaways for Senior Decision-Makers

  • Advanced next-generation sequencing technologies and precision bioinformatics are enabling more reliable and earlier identification of genetic abnormalities, supporting improved clinical outcomes in fertility care.
  • Integration of artificial intelligence and remote assessment tools is streamlining laboratory operations and improving access to specialized expertise, especially in regions with limited capacity.
  • Strategic collaborations between diagnostic technology developers and fertility care networks are accelerating innovation and broadening service offerings.
  • Variability in reimbursement structures continues to shape adoption rates, necessitating region-specific business models and policy engagement.
  • Localized manufacturing of reagents and instruments is emerging as a key strategy to manage supply chain risks and regulatory changes.
  • Market consolidation and alliance activity signal increased competition and the emergence of integrated workflow solutions for end users.

Tariff Impact on Preimplantation Genetic Testing

Recent tariff changes in the United States are affecting the pricing and supply dynamics for imported genomic instruments and reagents. These measures are encouraging stakeholders to invest in domestic production capabilities and fortify supplier relationships to maintain market access and cost predictability. Some clinics and laboratories are adjusting procurement and inventory strategies in response, while ongoing advocacy seeks targeted exemptions for essential diagnostic reagents. Domestic and regional manufacturing is expected to play a growing role in preserving service continuity.

Methodology & Data Sources

This analysis is built on a layered research process, including extensive secondary review of academic publications, regulatory records, and company literature. In-depth interviews with industry leaders and clinicians were used to validate insights and uncover emerging trends. Data triangulation, regional case studies, and peer-reviewed quality checks ensure actionable and credible findings.

Why This Report Matters

  • Enables executive teams to align resource allocation and technology investments with the most promising market segments and geographic growth opportunities.
  • Provides clarity on shifting regulatory landscapes, reimbursement strategies, and operational best practices within the global preimplantation genetic testing market.
  • Equips leaders with competitor intelligence and partnership trends essential for maintaining a competitive edge.

Conclusion

The preimplantation genetic testing market is poised for sustained growth as technological advances, regional market access, and evolving strategies converge. Stakeholders who act decisively on segmentation insights and adapt to global trends will strengthen their leadership as the field continues to advance.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Preimplantation Genetic Testing Market, by Testing Type
8.1. Introduction
8.2. PGT-A (Aneuploidy)
8.3. PGT-M (Monogenic Disorders)
8.4. PGT-SR (Structural Rearrangements)
9. Preimplantation Genetic Testing Market, by Test Type
9.1. Introduction
9.2. Preimplantation Genetic Diagnosis
9.3. Preimplantation Genetic Screening
10. Preimplantation Genetic Testing Market, by Technology Type
10.1. Introduction
10.2. Comparative Genomic Hybridization
10.3. Fluorescent In-Situ Hybridization
10.4. Next-Generation Sequencing
10.5. PCR-Based Testing
10.6. Single-Nucleotide Polymorphism
11. Preimplantation Genetic Testing Market, by Offering
11.1. Introduction
11.2. Instruments
11.3. Reagents & Consumables
11.4. Software
12. Preimplantation Genetic Testing Market, by End User
12.1. Introduction
12.2. Diagnostic Laboratories
12.3. Fertility Clinics
12.4. Hospitals
12.5. Research Institutes
13. Americas Preimplantation Genetic Testing Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Preimplantation Genetic Testing Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Preimplantation Genetic Testing Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Abbott Laboratories
16.3.2. Agilent Technologies, Inc.
16.3.3. Bio-Techne Corporation
16.3.4. Bioarray S.L.
16.3.5. EUROPE IVF International s.r.o.
16.3.6. F. Hoffmann-La Roche AG
16.3.7. Genea Limited
16.3.8. GENETiKS
16.3.9. Illumina, Inc.
16.3.10. Invicta Genetics
16.3.11. Invitae Corporation
16.3.12. Juno Genetics, US Inc.
16.3.13. Laboratory Corporation of America Holdings
16.3.14. MedGenome Labs Ltd.
16.3.15. Merck KGaA
16.3.16. Natera, Inc.
16.3.17. NextGen Genetics Holdings, LLC
16.3.18. Ovation Fertility
16.3.19. PacGenomics
16.3.20. PerkinElmer, Inc.
16.3.21. Progyny, Inc.
16.3.22. Qiagen N.V.
16.3.23. Quest Diagnostics Incorporated
16.3.24. Reproductive Genetic Innovations, LLC
16.3.25. SEQUENCE46, LLC
16.3.26. Sysmex Corporation
16.3.27. Takara Bio Inc.
16.3.28. The Cooper Companies Inc.
16.3.29. Thermo Fisher Scientific Inc.
16.3.30. Vitrolife Sweden AB
16.3.31. Yikon Genomics (Shanghai) Co., Ltd.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. PREIMPLANTATION GENETIC TESTING MARKET MULTI-CURRENCY
FIGURE 2. PREIMPLANTATION GENETIC TESTING MARKET MULTI-LANGUAGE
FIGURE 3. PREIMPLANTATION GENETIC TESTING MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2024 VS 2030 (%)
FIGURE 14. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. PREIMPLANTATION GENETIC TESTING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. PREIMPLANTATION GENETIC TESTING MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. PREIMPLANTATION GENETIC TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY PGT-A (ANEUPLOIDY), BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY PGT-M (MONOGENIC DISORDERS), BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY PGT-SR (STRUCTURAL REARRANGEMENTS), BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY PREIMPLANTATION GENETIC DIAGNOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY PREIMPLANTATION GENETIC SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY COMPARATIVE GENOMIC HYBRIDIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY FLUORESCENT IN-SITU HYBRIDIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY PCR-BASED TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY SINGLE-NUCLEOTIDE POLYMORPHISM, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY FERTILITY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 40. CANADA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 41. CANADA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 42. CANADA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 43. CANADA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 44. CANADA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 45. MEXICO PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 46. MEXICO PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 47. MEXICO PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 48. MEXICO PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 49. MEXICO PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 50. BRAZIL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 52. BRAZIL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 53. BRAZIL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 54. BRAZIL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 55. ARGENTINA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 56. ARGENTINA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 57. ARGENTINA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 58. ARGENTINA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 59. ARGENTINA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 60. EUROPE, MIDDLE EAST & AFRICA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 61. EUROPE, MIDDLE EAST & AFRICA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 62. EUROPE, MIDDLE EAST & AFRICA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 63. EUROPE, MIDDLE EAST & AFRICA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 64. EUROPE, MIDDLE EAST & AFRICA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 65. EUROPE, MIDDLE EAST & AFRICA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 66. UNITED KINGDOM PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 67. UNITED KINGDOM PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 68. UNITED KINGDOM PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 69. UNITED KINGDOM PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 70. UNITED KINGDOM PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 71. GERMANY PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 72. GERMANY PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 73. GERMANY PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 74. GERMANY PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 75. GERMANY PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 76. FRANCE PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 77. FRANCE PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 78. FRANCE PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 79. FRANCE PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 80. FRANCE PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 81. RUSSIA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 82. RUSSIA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 83. RUSSIA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 84. RUSSIA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 85. RUSSIA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 86. ITALY PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 87. ITALY PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 88. ITALY PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 89. ITALY PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 90. ITALY PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 91. SPAIN PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 92. SPAIN PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 93. SPAIN PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 94. SPAIN PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 95. SPAIN PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 96. UNITED ARAB EMIRATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 97. UNITED ARAB EMIRATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 98. UNITED ARAB EMIRATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 99. UNITED ARAB EMIRATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 100. UNITED ARAB EMIRATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 101. SAUDI ARABIA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 102. SAUDI ARABIA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 103. SAUDI ARABIA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 104. SAUDI ARABIA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 105. SAUDI ARABIA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 106. SOUTH AFRICA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 107. SOUTH AFRICA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 108. SOUTH AFRICA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 109. SOUTH AFRICA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 110. SOUTH AFRICA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 111. DENMARK PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 112. DENMARK PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 113. DENMARK PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 114. DENMARK PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 115. DENMARK PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 116. NETHERLANDS PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 117. NETHERLANDS PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 118. NETHERLANDS PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 119. NETHERLANDS PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 120. NETHERLANDS PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 121. QATAR PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 122. QATAR PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 123. QATAR PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 124. QATAR PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 125. QATAR PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. FINLAND PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 127. FINLAND PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 128. FINLAND PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 129. FINLAND PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 130. FINLAND PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 131. SWEDEN PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 132. SWEDEN PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 133. SWEDEN PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 134. SWEDEN PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 135. SWEDEN PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 136. NIGERIA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 137. NIGERIA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 138. NIGERIA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 139. NIGERIA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 140. NIGERIA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 141. EGYPT PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 142. EGYPT PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 143. EGYPT PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 144. EGYPT PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 145. EGYPT PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 146. TURKEY PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 147. TURKEY PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 148. TURKEY PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 149. TURKEY PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 150. TURKEY PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 151. ISRAEL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 152. ISRAEL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 153. ISRAEL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 154. ISRAEL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 155. ISRAEL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 156. NORWAY PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 157. NORWAY PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 158. NORWAY PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 159. NORWAY PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 160. NORWAY PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 161. POLAND PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 162. POLAND PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 163. POLAND PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 164. POLAND PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 165. POLAND PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 166. SWITZERLAND PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 167. SWITZERLAND PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 168. SWITZERLAND PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 169. SWITZERLAND PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 170. SWITZERLAND PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 171. ASIA-PACIFIC PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 172. ASIA-PACIFIC PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 173. ASIA-PACIFIC PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 174. ASIA-PACIFIC PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 175. ASIA-PACIFIC PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 176. ASIA-PACIFIC PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 177. CHINA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 178. CHINA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 179. CHINA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 180. CHINA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 181. CHINA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 182. INDIA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 183. INDIA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 184. INDIA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 185. INDIA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 186. INDIA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 187. JAPAN PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 188. JAPAN PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 189. JAPAN PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 190. JAPAN PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 191. JAPAN PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 192. AUSTRALIA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 193. AUSTRALIA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 194. AUSTRALIA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 195. AUSTRALIA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 196. AUSTRALIA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 197. SOUTH KOREA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 198. SOUTH KOREA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 199. SOUTH KOREA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 200. SOUTH KOREA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 201. SOUTH KOREA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 202. INDONESIA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 203. INDONESIA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 204. INDONESIA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 205. INDONESIA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 206. INDONESIA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 207. THAILAND PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 208. THAILAND PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 209. THAILAND PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 210. THAILAND PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 211. THAILAND PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 212. PHILIPPINES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 213. PHILIPPINES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 214. PHILIPPINES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 215. PHILIPPINES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 216. PHILIPPINES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 217. MALAYSIA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 218. MALAYSIA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 219. MALAYSIA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 220. MALAYSIA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 221. MALAYSIA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 222. SINGAPORE PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 223. SINGAPORE PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 224. SINGAPORE PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 225. SINGAPORE PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 226. SINGAPORE PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 227. VIETNAM PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 228. VIETNAM PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 229. VIETNAM PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 230. VIETNAM PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 231. VIETNAM PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 232. TAIWAN PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 233. TAIWAN PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 234. TAIWAN PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 235. TAIWAN PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 236. TAIWAN PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 237. PREIMPLANTATION GENETIC TESTING MARKET SHARE, BY KEY PLAYER, 2024
TABLE 238. PREIMPLANTATION GENETIC TESTING MARKET, FPNV POSITIONING MATRIX, 2024

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Preimplantation Genetic Testing market report include:
  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Bio-Techne Corporation
  • Bioarray S.L.
  • EUROPE IVF International s.r.o.
  • F. Hoffmann-La Roche AG
  • Genea Limited
  • GENETiKS
  • Illumina, Inc.
  • Invicta Genetics
  • Invitae Corporation
  • Juno Genetics, US Inc.
  • Laboratory Corporation of America Holdings
  • MedGenome Labs Ltd.
  • Merck KGaA
  • Natera, Inc.
  • NextGen Genetics Holdings, LLC
  • Ovation Fertility
  • PacGenomics
  • PerkinElmer, Inc.
  • Progyny, Inc.
  • Qiagen N.V.
  • Quest Diagnostics Incorporated
  • Reproductive Genetic Innovations, LLC
  • SEQUENCE46, LLC
  • Sysmex Corporation
  • Takara Bio Inc.
  • The Cooper Companies Inc.
  • Thermo Fisher Scientific Inc.
  • Vitrolife Sweden AB
  • Yikon Genomics (Shanghai) Co., Ltd.

Table Information

Report AttributeDetails
No. of Pages189
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 873.74 Million
Forecasted Market Value ( USD ) by 2030 $ 1550 Million
Compound Annual Growth Rate12.2%
Regions CoveredGlobal
No. of Companies Mentioned32

Related Topics

Related Reports

Preimplantation Genetic Testing Market Size, Share & Trends Analysis Report by Procedure, Product (Reagents & Consumables, Instruments, Software), Technology, Application (X-linked Diseases, Embryo Testing), End-use, and Region with Growth Forecasts, 2025-2030 - Product Image

Preimplantation Genetic Testing Market Size, Share & Trends Analysis Report by Procedure, Product (Reagents & Consumables, Instruments, Software), Technology, Application (X-linked Diseases, Embryo Testing), End-use, and Region with Growth Forecasts, 2025-2030

  • Report
  • 120 Pages
  • Global
From
Preimplantation Genetic Testing Market Outlook Report: Industry Size, Market Shares Data, Latest Trends, Insights, Growth Potential, CAGR Forecasts to 2034 - Product Image

Preimplantation Genetic Testing Market Outlook Report: Industry Size, Market Shares Data, Latest Trends, Insights, Growth Potential, CAGR Forecasts to 2034

  • Report
  • 150 Pages
  • Global
From
Preimplantation Genetic Testing Market Report 2025 - Product Image

Preimplantation Genetic Testing Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Preimplantation Genetic Testing - Global Strategic Business Report - Product Image

Preimplantation Genetic Testing - Global Strategic Business Report

  • Report
  • 89 Pages
  • Global
From
Preimplantation Genetic Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Preimplantation Genetic Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 182 Pages
  • Global
From

About the Preimplantation Genetic Diagnosis Market

Preimplantation Genetic Diagnosis (PGD) is a biotechnology procedure used to detect genetic abnormalities in embryos prior to implantation. It is used in conjunction with in vitro fertilization (IVF) to help couples with a family history of genetic disorders or those at risk of transmitting a genetic disorder to their offspring. PGD involves the removal of a single cell from an embryo and testing it for genetic abnormalities. The results of the test are then used to determine which embryos are suitable for implantation. PGD has been used to detect a wide range of genetic disorders, including cystic fibrosis, Down syndrome, and Huntington's disease. It has also been used to detect chromosomal abnormalities, such as aneuploidy, which can lead to miscarriage or birth defects. PGD has been used to select embryos for gender selection, as well as to select embryos for tissue typing for bone marrow transplantation. Companies in the Preimplantation Genetic Diagnosis market include Illumina, Inc., Thermo Fisher Scientific, Inc., PerkinElmer, Inc., Agilent Technologies, Inc., and Natera, Inc. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.